FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1974764716> ?p ?o ?g. }

• W1974764716 endingPage "149" @default.
• W1974764716 startingPage "139" @default.
• W1974764716 abstract "The cyclin-dependent kinase inhibitors known as p15, p16 and p18 have been suggested as candidates for tumour suppressor genes. We examined these genes for their alterations in 46 myeloid leukaemias and 15 myeloid leukaemia cell lines. p16 mRNA expression was studied in 41 myeloid leukaemias. The p15 and p16 genes were either deleted or mutated in myeloid leukaemia lines at a high frequency [6/15 (40%) for p15; 8/15 (53%) for p16] but alterations in primary myeloid leukaemias are much less frequent [2/46 (4%) for p15; 3/46 (6%) for p16]. Alterations of p18 were not found in any of the samples. 13 primary myeloid leukaemia samples had negligible levels of p16 mRNA. In summary, the deletions of p15 and p16 genes identified in the myeloid leukaemia cell lines probably occurred during their in vitro immortalization. Alterations of the p16 or p15 gene only occurred in primary acute myeloid leukaemia samples that were of mixed myeloid/lymphoid lineage (CD19/CD20-positive acute myeloid leukaemia [AML], CD2/CD19-positive AML, and lymphoid blastic crisis of chronic myeloid leukaemia). Further studies are required to determine if the absence of mRNA expression results from inactivation of the p16 gene." @default.
• W1974764716 created "2016-06-24" @default.
• W1974764716 creator A5000513493 @default.
• W1974764716 creator A5000852530 @default.
• W1974764716 creator A5015381826 @default.
• W1974764716 creator A5036293768 @default.
• W1974764716 creator A5049007948 @default.
• W1974764716 creator A5056427847 @default.
• W1974764716 creator A5061189755 @default.
• W1974764716 creator A5065223770 @default.
• W1974764716 creator A5066106726 @default.
• W1974764716 creator A5069775753 @default.
• W1974764716 creator A5081468712 @default.
• W1974764716 creator A5082903377 @default.
• W1974764716 creator A5085853288 @default.
• W1974764716 date "1995-09-01" @default.
• W1974764716 modified "2023-10-18" @default.
• W1974764716 title "Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias" @default.
• W1974764716 cites W1517159206 @default.
• W1974764716 cites W1560943589 @default.
• W1974764716 cites W1580617714 @default.
• W1974764716 cites W1909940207 @default.
• W1974764716 cites W1977299280 @default.
• W1974764716 cites W1983348452 @default.
• W1974764716 cites W1995022492 @default.
• W1974764716 cites W1996413533 @default.
• W1974764716 cites W1997073961 @default.
• W1974764716 cites W1997707998 @default.
• W1974764716 cites W1998001782 @default.
• W1974764716 cites W2003907692 @default.
• W1974764716 cites W200461798 @default.
• W1974764716 cites W2015519364 @default.
• W1974764716 cites W2017689200 @default.
• W1974764716 cites W2033156691 @default.
• W1974764716 cites W2035159808 @default.
• W1974764716 cites W2035975217 @default.
• W1974764716 cites W2037268137 @default.
• W1974764716 cites W2046577405 @default.
• W1974764716 cites W2058794167 @default.
• W1974764716 cites W2058879820 @default.
• W1974764716 cites W2065417936 @default.
• W1974764716 cites W2066657154 @default.
• W1974764716 cites W2066848701 @default.
• W1974764716 cites W2069008633 @default.
• W1974764716 cites W2070061120 @default.
• W1974764716 cites W2074067954 @default.
• W1974764716 cites W2076273397 @default.
• W1974764716 cites W2082668438 @default.
• W1974764716 cites W2089218510 @default.
• W1974764716 cites W2092357174 @default.
• W1974764716 cites W2109465247 @default.
• W1974764716 cites W2138544437 @default.
• W1974764716 cites W2153488262 @default.
• W1974764716 cites W2158350288 @default.
• W1974764716 cites W2244637994 @default.
• W1974764716 cites W2560672552 @default.
• W1974764716 cites W4231615136 @default.
• W1974764716 cites W4294216491 @default.
• W1974764716 cites W1995023099 @default.
• W1974764716 doi "https://doi.org/10.1111/j.1365-2141.1995.tb05259.x" @default.
• W1974764716 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7577621" @default.
• W1974764716 hasPublicationYear "1995" @default.
• W1974764716 type Work @default.
• W1974764716 sameAs 1974764716 @default.
• W1974764716 citedByCount "41" @default.
• W1974764716 countsByYear W19747647162012 @default.
• W1974764716 countsByYear W19747647162013 @default.
• W1974764716 countsByYear W19747647162016 @default.
• W1974764716 countsByYear W19747647162019 @default.
• W1974764716 countsByYear W19747647162022 @default.
• W1974764716 crossrefType "journal-article" @default.
• W1974764716 hasAuthorship W1974764716A5000513493 @default.
• W1974764716 hasAuthorship W1974764716A5000852530 @default.
• W1974764716 hasAuthorship W1974764716A5015381826 @default.
• W1974764716 hasAuthorship W1974764716A5036293768 @default.
• W1974764716 hasAuthorship W1974764716A5049007948 @default.
• W1974764716 hasAuthorship W1974764716A5056427847 @default.
• W1974764716 hasAuthorship W1974764716A5061189755 @default.
• W1974764716 hasAuthorship W1974764716A5065223770 @default.
• W1974764716 hasAuthorship W1974764716A5066106726 @default.
• W1974764716 hasAuthorship W1974764716A5069775753 @default.
• W1974764716 hasAuthorship W1974764716A5081468712 @default.
• W1974764716 hasAuthorship W1974764716A5082903377 @default.
• W1974764716 hasAuthorship W1974764716A5085853288 @default.
• W1974764716 hasConcept C104317684 @default.
• W1974764716 hasConcept C147483822 @default.
• W1974764716 hasConcept C203014093 @default.
• W1974764716 hasConcept C2778264664 @default.
• W1974764716 hasConcept C2778729363 @default.
• W1974764716 hasConcept C2778957590 @default.
• W1974764716 hasConcept C2779282312 @default.
• W1974764716 hasConcept C502942594 @default.
• W1974764716 hasConcept C54355233 @default.
• W1974764716 hasConcept C555283112 @default.
• W1974764716 hasConcept C86803240 @default.
• W1974764716 hasConceptScore W1974764716C104317684 @default.
• W1974764716 hasConceptScore W1974764716C147483822 @default.
• W1974764716 hasConceptScore W1974764716C203014093 @default.

• next